Fr. 148.90

Pediatric Psychopharmacology: A Practical Guide

Englisch · Fester Einband

Versand in der Regel in mind. 4 Wochen (Titel wird speziell besorgt)

Beschreibung

Mehr lesen










This book will provide up-to-date practical information in a form that is readily accessible and clinically relevant. It will be distinguished from other resources available by innovative use of graphics to convey data such as drug mechanisms and class differences.

Inhaltsverzeichnis










Section One: Essentials of Prescribing Psychotropic Medications to Children
Chapter 1: Psychopharmacology Evaluation

Clinical Interview

Useful rating scales

Review of old records

Relevance of neuropsychological testing

Collateral information

Necessary baseline data (vitals, EKG, labs)

Identifying target symptoms

Beyond the evaluation: when to follow up, etc)

Chapter 2: Talking to Parents about Medications

Discussing pros and cons of starting medication

Practical tips about administering meds (which meds can be crushed, what to mix them with, getting kids to swallow pills)

Chapter 3: Legal Issues in Prescribing

Informed consent issues (how to discuss off label and non-FDA approved medications, issues of shared legal custody)

Recordkeeping

Chapter 4: Suicide and Psychopharmacology

Evaluating the suicidal patient

Suicide and medications: FDA black box warnings


Section Two: Psychotropic Medications
Chapter 5: Psychostimulants and other drugs for ADHD
Methylphenidates
Ritalin and Ritalin LA
Focalin and Focalin XR
Metadate CD
Concerta
Daytrana
Amphetamines
Dexedrine
Adderall and Adderall XR
Lisdexamphetamine
Atomoxetine
Extended Release Guanfacine
Alternative medications that have been studied but are not approved Bupropion, TCAs, Modafinil, (maybe R-Modafinil), Clonidine, Guanfacine, Selegiline, Reboxetine maybe others
Chapter 6: Specific Serotonin Reuptake Inhibitors (SSRIs)
Fluoxetine
Sertraline
Paroxetine
Fluvoxamine
Citalapram
Escitalapram
Chapter 7 Other antidepressants
Bupropion
Mirtazepine
Trazodone
Venlafaxine
Duloxetine
Tricyclic antidepressants
MAOIs
Chapter 8: Antipsychotics
Atypical Antipsychotics
Risperidone
Paliperidone
Quetiapine
Olanzapine
Ziprasidone
Aripiprazole
Clozapine
Typical Antipsychotics
Haloperidol
Thioridazine
? Additional
Chapter 9: Mood Stabilizers
Lithium
Valproate
Lamotrigine
Others (Carbamazepine, Gabapentin, Oxcarbazine, Topiramate, Leveracitam, Zonegran)
Chapter 10: Benzodiazepines
Lorazepam
Clonazepam
Diazepam
Chapter 11: Adrenergic Agents
Clonidine
Guanfacine, Guanfacine ER
Beta blockers
Chapter 12: Over the Counter Sleep Medications
Diphenhydramine
Melatonin
Chapter 13: Medications for Enuresis and Encopresis
ddAVP
Miralax
Tricyclic antidepressants
Chapter 14: Medications used in the Treatment of Addictions
Disulfiram
Acamprosate
Naltrexone
Methadone
Varenicline
Suboxone


Section Three: Treatment of Common Psychiatric Disorders
Chapter 15: Attention Deficit/Hyperactivity Disorder
Chapter 16: Disruptive Disorders
Oppositional Defiant Disorder
Conduct Disorder
Aggression (including management of aggressive patient in inpatient unit, ER)
Chapter 17: Depression
Chapter 18: Bipolar Disorder
Chapter 19: Anxiety Disorders
Chapter 20: Pervasive Developmental Disorders
Chapter 21: Tic Spectrum Disorders
Chapter 22: Eating Disorders
Chapter 23: Elimination Disorders: Enuresis and Encopresis
Chapter 24: Sleep Disorders
Chapter 25: Substance Use Disorders
Chapter 26: Psychotic Disorders (including managing extrapyramidal side effects)
Section One: Essentials of Prescribing Psychotropic Medications to Children
Chapter 1: Psychopharmacology Evaluation

Clinical Interview

Useful rating scales

Review of old records

Relevance of neuropsychological testing

Collateral information

Necessary baseline data (vitals, EKG, labs)

Identifying target symptoms

Beyond the evaluation: when to follow up, etc)

Chapter 2: Talking to Parents about Medications

Discussing pros and cons of starting medication

Practical tips about administering meds (which meds can be crushed, what to mix them with, getting kids to swallow pills)

Chapter 3: Legal Issues in Prescribing

Informed consent issues (how to discuss off label and non-FDA approved medications, issues of shared legal custody)

Recordkeeping

Chapter 4: Suicide and Psychopharmacology

Evaluating the suicidal patient

Suicide and medications: FDA black box warnings


Section Two: Psychotropic Medications
Chapter 5: Psychostimulants and other drugs for ADHD
Methylphenidates
Ritalin and Ritalin LA
Focalin and Focalin XR
Metadate CD
Concerta
Daytrana
Amphetamines
Dexedrine
Adderall and Adderall XR
Lisdexamphetamine
Atomoxetine
Extended Release Guanfacine
Alternative medications that have been studied but are not approved Bupropion, TCAs, Modafinil, (maybe R-Modafinil), Clonidine, Guanfacine, Selegiline, Reboxetine maybe others
Chapter 6: Specific Serotonin Reuptake Inhibitors (SSRIs)
Fluoxetine
Sertraline
Paroxetine
Fluvoxamine
Citalapram
Escitalapram
Chapter 7 Other antidepressants
Bupropion
Mirtazepine
Trazodone
Venlafaxine
Duloxetine
Tricyclic antidepressants
MAOIs
Chapter 8: Antipsychotics
Atypical Antipsychotics
Risperidone
Paliperidone
Quetiapine
Olanzapine
Ziprasidone
Aripiprazole
Clozapine
Typical Antipsychotics
Haloperidol
Thioridazine
? Additional
Chapter 9: Mood Stabilizers
Lithium
Valproate
Lamotrigine
Others (Carbamazepine, Gabapentin, Oxcarbazine, Topiramate, Leveracitam, Zonegran)
Chapter 10: Benzodiazepines
Lorazepam
Clonazepam
Diazepam
Chapter 11: Adrenergic Agents
Clonidine
Guanfacine, Guanfacine ER
Beta blockers
Chapter 12: Over the Counter Sleep Medications
Diphenhydramine
Melatonin
Chapter 13: Medications for Enuresis and Encopresis
ddAVP
Miralax
Tricyclic antidepressants
Chapter 14: Medications used in the Treatment of Addictions
Disulfiram
Acamprosate
Naltrexone
Methadone
Varenicline
Suboxone


Section Three: Treatment of Common Psychiatric Disorders
Chapter 15: Attention Deficit/Hyperactivity Disorder
Chapter 16: Disruptive Disorders
Oppositional Defiant Disorder
Conduct Disorder
Aggression (including management of aggressive patient in inpatient unit, ER)
Chapter 17: Depression
Chapter 18: Bipolar Disorder
Chapter 19: Anxiety Disorders
Chapter 20: Pervasive Developmental Disorders
Chapter 21: Tic Spectrum Disorders
Chapter 22: Eating Disorders
Chapter 23: Elimination Disorders: Enuresis and Encopresis
Chapter 24: Sleep Disorders
Chapter 25: Substance Use Disorders
Chapter 26: Psychotic Disorders (including managing extrapyramidal side effects)


Produktdetails

Mitarbeit Jeffrey Q. Bostic (Herausgeber), Jefferson Prince (Herausgeber), Kristen Smith Russell (Herausgeber)
Verlag Springer London
 
Sprache Englisch
Produktform Fester Einband
Erschienen 01.10.2012
 
EAN 9781607616399
ISBN 978-1-60761-639-9
Seiten 325
Serie Current Clinical Psychiatry
Thema Naturwissenschaften, Medizin, Informatik, Technik > Medizin > Nichtklinische Fächer

Kundenrezensionen

Zu diesem Artikel wurden noch keine Rezensionen verfasst. Schreibe die erste Bewertung und sei anderen Benutzern bei der Kaufentscheidung behilflich.

Schreibe eine Rezension

Top oder Flop? Schreibe deine eigene Rezension.

Für Mitteilungen an CeDe.ch kannst du das Kontaktformular benutzen.

Die mit * markierten Eingabefelder müssen zwingend ausgefüllt werden.

Mit dem Absenden dieses Formulars erklärst du dich mit unseren Datenschutzbestimmungen einverstanden.